Medication neurotoxicity in children

Pediatric Radiology

Volumn 41, Issue 11, 2011, Pages 1455-1464

  Iyer, Ramesh S ^a   Chaturvedi, Apeksha ^a   Pruthi, Sumit ^b   Khanna, Paritosh C ^a   Ishak, Gisele E ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

Acute toxic leukoencephalopathy; Children; Medication neurotoxicity; Posterior reversible leukoencephalopathy syndrome

Indexed keywords

BEVACIZUMAB; CYCLOSPORIN A; METHOTREXATE; METRONIDAZOLE; TACROLIMUS; VIGABATRIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE TOXIC LEUKOENCEPHALOPATHY; AGE; ATAXIA; BASAL GANGLION; BRAIN ATROPHY; BRAIN DISEASE; BRAIN EDEMA; BRAIN FORNIX; BRAIN HEMORRHAGE; BRAIN STEM; CEREBELLUM ATROPHY; COMA; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; CORPUS CALLOSUM SPLENIUM; CROHN DISEASE; DEMENTIA; DENTATE NUCLEUS; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSARTHRIA; FLUID ATTENUATED INVERSION RECOVERY; FRONTAL LOBE; GLOBUS PALLIDUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAY MATTER; HUMAN; LEUKOENCEPHALOPATHY; NEUROIMAGING; NEUROPATHY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PATHOPHYSIOLOGY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW; RISK FACTOR; SEIZURE; THALAMUS; TUBEROUS SCLEROSIS; ULCERATIVE COLITIS; VASOGENIC EDEMA; WHITE MATTER;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTI-INFECTIVE AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; METRONIDAZOLE; NEUROTOXICITY SYNDROMES; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; TACROLIMUS; YOUNG ADULT;

EID: 80755146158     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-011-2191-3     Document Type: Review

References (51)

1. J Hinchey C Chaves B Appignani, et al. 1996 A reversible posterior leukoencephalopathy syndrome N Engl J Med 334 494 500 8559202 10.1056/NEJM199602223340803 1:STN:280:DyaK287lslSisQ%3D%3D (Pubitemid 26067737)
2. MS Ugurel M Hayakawa 2005 Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome Eur J Radiol 53 441 449 15741018 10.1016/j.ejrad.2004.05.015 (Pubitemid 40312134)
3. HM Hefzy WS Bartynski JF Boardman, et al. 2009 Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features AJNR 30 1371 1379 19386731 10.3174/ajnr.A1588 1:STN:280:DC%2BD1Mrkt1Cntg%3D%3D
4. F Incecik MO Hergüner S Altunbasak, et al. 2009 Evaluation of nine children with reversible posterior encephalopathy syndrome Neurol India 57 475 478 19770551 10.4103/0028-3886.55605
5. AM McKinney J Short CL Truwit, et al. 2007 Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings AJR 189 904 912 17885064 10.2214/AJR.07.2024 (Pubitemid 47485623)
6. SO Casey RC Sampaio E Michel, et al. 2000 Posterior reversible encephalopathy syndrome: utility of fluid attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions AJNR 21 1199 1206 10954269 1:STN:280:DC%2BD3M%2FotlOgtg%3D%3D (Pubitemid 30655653)
7. SO Casey CL Truwit 2000 Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy? AJNR 21 243 245 10696002 1:STN:280:DC%2BD3c7lvVGnuw%3D%3D (Pubitemid 30102146)
8. P Mukherjee RC McKinstry 2001 Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor imaging Radiology 219 756 765 11376265 1:STN:280:DC%2BD3M3ps1yruw%3D%3D (Pubitemid 32476268)
9. DJ Covarrubias PH Luetmer NG Campeau 2002 Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images AJNR 23 1038 1048 12063238 (Pubitemid 34663453)
10. RB Schwartz SK Feske JF Polak, et al. 2000 Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy Radiology 217 371 376 11058630 1:STN:280: DC%2BD3crhtFeruw%3D%3D
11. JM Provenzale JR Petrella LC Cruz Jr, et al. 2001 Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome AJNR 22 1455 1461 11559490 1:STN:280:DC%2BD3MrhtFKjsw%3D%3D (Pubitemid 32862254)
12. K Tamaki S Sadoshima GL Baumbach, et al. 1984 Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy Hypertension 6 2 Pt 2 I75 I81 6724673 1:STN:280:DyaL2c3htFShsA%3D%3D
13. BL Trommer D Homer MA Mikhael 1988 Cerebral vasospasm and eclampsia Stroke 19 326 329 3354016 10.1161/01.STR.19.3.326 1:STN:280:DyaL1c7nvVymuw%3D%3D
14. T Ito T Sakai S Inagawa, et al. 1995 MR angiography of cerebral vasospasm in preeclampsia AJNR 16 1344 1346 7677037 1:STN:280:DyaK2MvgslGitw%3D%3D
15. AM McKinney SA Kieffer RT Paylor, et al. 2009 Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging AJR 193 192 206 19542414 10.2214/AJR.08.1176
16. A Beitinjaneh AM McKinney Q Cao, et al. 2011 Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation Biol Blood Marrow Transplant 17 300 308 20399878 10.1016/j.bbmt.2010.04.003 1:CAS:528:DC%2BC3MXhvV2qsbg%3D
17. CM Filley 1999 Toxic leukoencephalopathy Clin Neuropharmacol 22 249 260 10516874 1:CAS:528:DyaK1MXmvVyksLc%3D (Pubitemid 29506393)
18. CM Filley 2001 Toxic leukoencephalopathy N Engl J Med 345 425 432 11496854 10.1056/NEJM200108093450606 1:CAS:528:DC%2BD3MXmsV2ls7g%3D (Pubitemid 32750305)
19. C Sandoval M Kutscher S Jayabose, et al. 2003 Neurotoxicity of intrathecal methotrexate: MR imaging findings AJNR 24 1887 1890 14561622 (Pubitemid 37280543)
20. N Rollins N Winick R Bash, et al. 2004 Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome AJNR 25 1688 1695 15569732 (Pubitemid 44123692)
21. M Shibutani R Okeda 1989 Experimental study on subacute neurotoxicity of methotrexate in cats Acta Neuropathol 78 291 300 2763801 10.1007/BF00687759 1:CAS:528:DyaL1MXltVylsbc%3D (Pubitemid 19182494)
22. T Akiba R Okeda T Tajima 1996 Metabolites of 5-fluorouracil, alpha-fluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture Acta Neuropathol 92 8 13 8811119 10.1007/s004010050482 1:CAS:528:DyaK28XkslSlurg%3D (Pubitemid 26192076)
23. R Okeda M Shibutani T Matsuo, et al. 1990 Experimental neurotoxicity of 5-fluorouracil and its derivatives is due to poisoning by the monofluorinated organic metabolites, monofluoroacetic acid and alpha-fluoro-beta-alanine Acta Neuropathol 81 66 73 2128162 10.1007/BF00662639 1:CAS:528:DyaK3MXhvF2itb4%3D (Pubitemid 20377478)
24. MJ Fisher ZP Khademian EM Simon, et al. 2005 Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children AJNR 26 1686 1689 16091514 (Pubitemid 43853664)
25. JM Chessels TC Cox B Kendall, et al. 1990 Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation Arch Dis Child 65 416 422 10.1136/adc.65.4.416 (Pubitemid 20145470)
26. N Jaffe Y Takaue T Anzai, et al. 1985 Transient neurologic disturbances induced by high-dose methotrexate treatment Cancer 56 1356 1360 3875390 10.1002/1097-0142(19850915)56:6<1356::AID-CNCR2820560623>3.0.CO;2-H 1:STN:280:DyaL2M3otF2kuw%3D%3D (Pubitemid 15230582)
27. GM Gowan JD Herrington AB Simonetta 2002 Methotrexate induced toxic leukoencephalopathy Pharmacotherapy 22 1183 1187 12222556 10.1592/phco.22.13. 1183.33528
28. K Matsumoto S Takahashi A Sato, et al. 1995 Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy: an MR analysis Int J Radiat Oncol Biol Phys 32 913 918 7607965 10.1016/0360-3016(95)00565-G 1:STN:280:DyaK2Mzjt1SqtA%3D%3D
29. HH Lien V Blomlie G Saeter, et al. 1991 Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate Radiology 179 547 550 2014309 1:STN:280:DyaK3M7psFGgtQ%3D%3D
30. R Rosencrantz A Moon H Raynes, et al. 2001 Cyclosporine-induced neurotoxicity during treatment of Crohn's disease: lack of correlation with previously reported risk factors Am J Gastroenterol 92 2778 2782 10.1111/j.1572-0241.2001.04111.x
31. F Trullemans F Grignard B Van Camp, et al. 2001 Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogenic bone marrow transplantation Eur J Haematol 67 94 99 11722596 10.1034/j.1600-0609.2001.t01-1-00440.x 1:STN:280:DC%2BD3MnnsFGgtw%3D%3D (Pubitemid 33010384)
32. WS Bartynski Z Zeigler MP Spearman, et al. 2001 Etiology of cortical and white matter lesions in cyclosporine-A and FK-506 neurotoxicity AJNR 22 1901 1914 11733324 1:STN:280:DC%2BD3Mnos1ygsA%3D%3D (Pubitemid 33091961)
33. MR Lucey JC Kolars RM Merion, et al. 1990 Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA Lancet 335 11 15 1967328 10.1016/0140-6736(90)90137-T 1:STN:280:DyaK3c7htlGhtw%3D%3D (Pubitemid 20020421)
34. DE Reece DA Frei-Lahr JD Shephard, et al. 1991 Neurologic complications in allogenic bone marrow transplant patients receiving cyclosporin Bone Marrow Transplant 8 393 401 1768975 1:STN:280:DyaK387hvFGgtQ%3D%3D
35. JM Gijtenbeek MJ van den Bent CJ Vecht 1999 Cyclosporine neurotoxicity: a review J Neurol 246 339 346 10399863 10.1007/s004150050360 1:STN:280: DyaK1MzisFCmsg%3D%3D (Pubitemid 29261421)
36. RB Schwartz SM Bravo RA Klufas, et al. 1995 Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases AJR 165 627 631 7645483 1:STN:280:DyaK2MzntlChtQ%3D%3D
37. BA Appignani RA Bhadelia SC Blacklow, et al. 1996 Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity AJR 166 683 688 8623651 1:STN:280:DyaK283gtFequw%3D%3D (Pubitemid 26065184)
38. F Lacaille L Hertz-Pannier MC Nassogne 2004 Magnetic resonance imaging for the diagnosis of acute leukoencephalopathy in children treated with tacrolimus Neuropediatrics 35 130 133 15127313 10.1055/s-2004-815835 1:STN:280:DC%2BD2c3ivValug%3D%3D (Pubitemid 38639321)
39. KF Ahn JW Lee ST Hahn, et al. 2003 Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity Br J Radiol 76 916 919 14711782 10.1259/bjr/77297900 1:STN:280:DC%2BD2c%2FhsVCltQ%3D%3D (Pubitemid 38124518)
40. CD Freeman NE Klutman KC Lamp 1997 Metronidazole: a therapeutic review and update Drugs 54 679 708 9360057 10.2165/00003495-199754050-00003 1:CAS:528:DyaK2sXntlyiurw%3D
41. S Frytak CH Moertel DS Childs 1978 Neurologic toxicity associated with high-dose metronidazole therapy Ann Intern Med 88 361 362 629500 1:STN:280:DyaE1c7it1eitA%3D%3D (Pubitemid 8287474)
42. E Kim DG Na EY Kim, et al. 2007 MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings AJNR 28 1652 1658 17885234 10.3174/ajnr.A0655 1:STN:280:DC%2BD2srpvVOhtg%3D%3D (Pubitemid 47598134)
43. CJ Heaney NG Campeau EP Lindell 2003 MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity AJNR 24 1615 1617 13679281 (Pubitemid 37151730)
44. A Ahmed DJ Loes EL Bressler 1995 Reversible resonance imaging findings in metronidazole-induced encephalopathy Neurology 45 588 589 7898724 1:STN:280:DyaK2M3gs1GmsQ%3D%3D
45. KM Cecil MJ Halsted M Schapiro, et al. 2002 Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy J Comput Assist Tomogr 26 948 951 12488741 10.1097/00004728-200211000-00016 (Pubitemid 36076712)
46. A McErlean K Abdalia V Donoghue, et al. 2010 The dentate nucleus in children: normal development and patterns of disease Pediatr Radiol 40 326 339 20107778 10.1007/s00247-009-1504-2
47. PL Pearl LG Vezina RP Saneto, et al. 2009 Cerebral MRI abnormalities associated with vigabatrin therapy Epilepsia 50 184 194 18783433 10.1111/j.1528-1167.2008.01728.x 1:CAS:528:DC%2BD1MXjtlWmtLo%3D
48. Y Ben-Ari 2006 Basic developmental rules and their implications for epilepsy in the immature brain Epileptic Disord 8 91 102 16793570 (Pubitemid 44013151)
49. A Dracopoulos E Widjaja C Raybaud, et al. 2010 Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms Epilepsia 51 1297 1304 20384718 10.1111/j.1528-1167.2010.02564.x
50. JW Wheless L Carmant M Bebin, et al. 2009 Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy Epilepsia 50 195 205 19054414 10.1111/j.1528-1167.2008.01896.x 1:CAS:528:DC%2BD1MXjtlWmtLs%3D
51. M Thapa PC Khanna 2010 Vigabatrin-associated diffusion MRI abnormalities in tuberous sclerosis Pediatr Radiol 48 Suppl 1 S153 10.1007/s00247-010-1838-9